微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-050352 Size: 7 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-049452 Size: 7 KB 网页链接
$Exagen(XGN)$ 内部交易: 2020-08-18,Director,TULLIS JAMES L L ,卖出,2082普通股, $14.52
$Exagen(XGN)$ 内部交易: 2020-08-14,Director,TULLIS JAMES L L ,卖出,11507普通股, $16.95
$Exagen(XGN)$ 内部交易: 2020-08-14,Director,TULLIS JAMES L L ,卖出,1398普通股, $16.95
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-047275 Size: 9 KB 网页链接
$Exagen(XGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001274737-20-000077 Act: 34 Size: 6 MB 网页链接
$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-20-000074 Act: 34 Size: 223 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-20-000070 Size: 9 KB 网页链接
$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274737-20-000066 Size: 5 KB 网页链接